Related Experiment Video
Updated: Jul 18, 2025

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
Published on: June 23, 2019
Current development of pyrazole-azole hybrids with anticancer potential
Shu Zhang1, Yun Ye2, Qiang Zhang1
1Hubei Key Laboratory of Pollution Damage Assessment & Environmental Health Risk Prevention & Control, Hubei Provincial Academy of Eco-Environmental Sciences, Wuhan, Hubei, 430000, PR China.
Abstract:
Chemotherapy is a critical treatment modality for cancer patients, but multidrug resistance remains one of the major challenges in cancer therapy, creating an urgent need for the development of novel potent chemical entities. Azoles, particularly pyrazole, could interact with different biological targets and exhibit diverse biological properties including anticancer activity. Many clinically used anticancer agents own an azole moiety, demonstrating that azoles are privileged and pivotal templates in the discovery of novel anticancer chemotherapeutics. The present article is an attempt to highlight the recent advances in pyrazole-azole hybrids with anticancer potential and discuss the structure-activity relationships, covering articles published from 2018 to present, to facilitate the rational design of more effective anticancer candidates.
Insights
Novel pyrazole-azole hybrids show promise as anticancer agents, addressing challenges in chemotherapy. This review highlights recent advances and structure-activity relationships to guide the development of more effective cancer therapeutics.
Area of Science:
- Medicinal Chemistry
- Oncology
- Drug Discovery
Background:
- Multidrug resistance is a major challenge in cancer chemotherapy, necessitating new therapeutic agents.
- Azole compounds, especially pyrazoles, possess diverse biological activities, including anticancer potential.
- Azole moieties are present in several approved anticancer drugs, indicating their significance in drug design.
Purpose of the Study:
- To review recent advancements in pyrazole-azole hybrids with demonstrated anticancer activity.
- To discuss structure-activity relationships (SAR) of these compounds.
- To aid in the rational design of novel anticancer drug candidates.
Main Methods:
- Literature search for articles published from 2018 to present.
- Analysis of reported anticancer activities of pyrazole-azole hybrids.
- Evaluation of SAR based on structural modifications and their impact on efficacy.
Main Results:
- Identification of various pyrazole-azole hybrids exhibiting significant in vitro and in vivo anticancer effects.
- Correlation of specific structural features with enhanced potency and selectivity against cancer cell lines.
- Insights into mechanisms of action for promising compounds.
Conclusions:
- Pyrazole-azole hybrids represent a promising scaffold for developing novel anticancer drugs.
- Understanding SAR is crucial for optimizing the design of these hybrids.
- Further research is warranted to translate these findings into clinical applications.
Related Concept Videos
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Five-Membered Heterocyclic Aromatic Compounds: Overview
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Basicity of Heterocyclic Aromatic Amines
Nucleophilic Aromatic Substitution of Aryldiazonium Salts: Aromatic SN1
In the Sandmeyer reaction, for example, the diazonio group is replaced by a chloro, bromo,...

![Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60786.jpg&w=3840&q=50)